Microbiología y Enfermedades Infecciosas
Aguirre F, Marro MJ, Rodríguez PE, Rall P, Miglietta EA, Miranda LAL, Poncet V, Pascuale CA, Ballejo CA, Ricardo T, Miragaya Y, Gamarnik A, Rossi AH, Silva AP. Efecto de la exposición previa a COVID-19, ocurrencia de brotes y tipo de vacuna en la respuesta inmune humoral de adultos mayores institucionalizados. Cadernos de sau?de pu?blica. 2024 Oct 11;40(9):e00155023. https://doi.org/10.1590/0102-311XES155023 Research Article Pubmed
Castellano LA, McNamara RJ, Pallarés HM, Gamarnik AV, Alvarez DE, Bazzini AA. Dengue virus preferentially uses human and mosquito non-optimal codons. Molecular Systems Biology. 2024 20(10):1085-1108. https://doi.org/10.1038/s44320-024-00052-7 Research article Pubmed
Pallarés HM, González López Ledesma MM, Oviedo-Rouco S, Castellano LA, Costa Navarro GS, Fernández-Alvarez AJ, D'Andreiz MJ, Aldas-Bulos VD, Alvarez DE, Bazzini AA, Gamarnik AV. Zika virus non-coding RNAs antagonize antiviral responses by PKR-mediated translational arrest. Nucleic Acids Research 2024 Jun 25:gkae507. doi: https://doi.org/10.1093/nar/gkae507 Pubmed
Peri Ibáñez ES, Mazzeo A, Silva C, Juncos MJ, Costa Navarro GS, Pallarés HM, Wolos VJ, Fiszman GL, Mundo SL, Caramelo JJ, Yanovsky MJ, Fingermann M, Castello AA, Gamarnik AV, Peinetti AS, Capdevila DA. Overcoming Limited Access to Virus Infection Rapid Testing: Development of a Lateral Flow Test for SARS-CoV-2 with Locally Available Resources. Biosensors. 2024 14(9):416. https://doi.org/10.3390/bios14090416 Research article Pubmed
Bottero D, Rudi E, Martin Aispuro P, Zurita E, Gaillard E, Gonzalez Lopez Ledesma MM, Malito J, Stuible M, Ambrosis N, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D. Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron. Frontiers in Immunology. Nov 10;14:1271209. 2023. doi: 10.3389/fimmu.2023.1271209. PubMed
Giai C, Salassa BN, Zarelli VE, Bello OD, Vanrell MC, Ojeda DS, Gamarnik A, Colombo MI. Comparative analysis of humoral immune response upon the three first vaccines applied in Argentina: IgG production and neutralizing capacity against SARS-CoV-2. Heliyon. 9(5):e15211 2023.. doi: 10.1016/j.heliyon.2023.e15211. PubMed
Gonzalez Lopez Ledesma MM, Costa Navarro G, Pallares HM, Paletta A, De Maio F, Iglesias NG, Gebhard L, Oviedo Rouco S, Ojeda DS, de Borba L, Giraldo M, Rajsbaum R, Ceballos A, Krogan NJ, Shah PS, Gamarnik AV. Dengue virus NS5 degrades ERC1 during infection to antagonize NF-kB activation. Proc Natl Acad Sci U S A. 120(23):e2220005120 2023.. doi: 10.1073/pnas.2220005120. PubMed
Adler NS, Cababie LA, Sarto C, Cavasotto CN, Gebhard LG, Estrin DA, Gamarnik AV, Arrar M, Kaufman SB. Insights into the product release mechanism of dengue virus NS3 helicase. Nucleic Acids Res. 50(12):6968-6979 2022.. doi: 10.1093/nar/gkac473. PubMed
Gabriel MV, Sallaberry I, Costa Navarro GS, Gratton E, Gamarnik AV, Estrada LC. Dengue Virus Capsid-Protein Dynamics in Live Infected Cells Studied by Pair Correlation Analysis. Methods Mol Biol. 2409:99-117 2022.. doi: 10.1007/978-1-0716-1879-0_8. PubMed
Gonzalez Lopez Ledesma MM, Sanchez L, Ojeda DS, Oviedo Rouco S, Rossi AH, Varese A, Mazzitelli I, Pascuale CA, Miglietta EA, Rodríguez PE, Pallarés HM, Costa Navarro GS, Caramelo JJ, Rothlauf PW, Liu Z, Bloyet LM, Cornejo Pontelli M, Rasetto NB, Wenker SD, Ramis LY, Bialer MG, de Leone MJ, Hernando CE, Bianchimano L, Ríos AS, Treffinger Cienfuegos MS, Rodriguez García DR, Longueira Y, Laufer N, Alvarez D, Ceballos A, Ochoa V, Monzani C, Turk G, Salvatori M, Carradori J, Prost K, Rima A, Varela C, Ercole R, Toro RI, Gutierrez S, Zubieta M, Acuña D, Nabaes Jodar MS, Torres C, Mojsiejczuk L, Viegas M, Velazquez P, Testa C, Kreplak N, Yanovsky M, Whelan S, Geffner J, Pifano M, Gamarnik AV. Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time. mBio. 13(1):e0344221 2022.. doi: 10.1128/mbio.03442-21. PubMed
Longueira Y, Ojeda DS, Battistelli RBA, Sanchez L, Oviedo Rouco S, Albano D, Guevara E, Valls V, Pando MA, Gamarnik AV. SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants. Front Immunol. 13:909995 2022.. doi: 10.3389/fimmu.2022.909995. PubMed
Pascuale CA, Varese A, Ojeda DS, Pasinovich ME, Lopez L, Rossi AH, Rodriguez PE, Miglietta EA; Laboratorio SeVa Group, Mazzitelli I, Di Diego Garcia F, Sanchez L, Rouco SO, Gonzalez Lopez Ledesma MM, Zurano JP, Mazzitelli B, Scruzzi G, Barbero P, Cardozo D, Gallego S, Borda M, Diaz M; Ministerio de Salud de la Provincia de Córdoba Group; UNC-Fac. Cs. Médicas-InViV Group, Ridao F, Rosales AB; Ministerio de Salud de la Provincia de La Rioja Group, Bhon J, Talia JM, Diangelo ME, Lacaze MA; Ministerio de Salud de la Provincia de San Luis Group, Aime B, Gutierrez SI, Ercole R, Toro R, Tau L, Delaplace L, Compagnucci MF; Universidad Nacional de La Plata Group, Sartori C, Desimone I, Echegoyen C, Velazquez P, Testa C; Ministerio de Salud de la Provincia de Buenos Aires Group, Hozbor D, Docena G, Laino CH, Kreplak N, Pifano M, Barbas G, Rearte A, Vizzotti C, Castelli JM, Geffner J, Gamarnik AV. Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273. Cell Rep Med. 3(8):100706 2022.. doi: 10.1016/j.xcrm.2022.100706. PubMed
Pecora A, Malacari DA, Mozgovoj MV, Díaz MLA, Peralta AV, Cacciabue M, Puebla AF, Carusso C, Mundo SL, Gonzalez Lopez Ledesma MM, Gamarnik AV, Rinaldi O, Vidal O, Mas J, Dus Santos MJ. Anthropogenic Infection of Domestic Cats With SARS-CoV-2 Alpha Variant B.1.1.7 Lineage in Buenos Aires. Front Vet Sci. 9:790058 2022.. doi: 10.3389/fvets.2022.790058. PubMed
Rodriguez PE, Silva AP, Miglietta EA, Rall P, Pascuale CA, Ballejo C, López Miranda L, Ríos AS, Ramis L, Marro J, Poncet V, Mazzitelli B, Salvatori M, Ceballos A, Gonzalez Lopez Ledesma MM, Ojeda DS, Aguirre MF, Miragaya Y, Gamarnik AV, Rossi AH; Laboratorio SeVa Group; PAMI Group. Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina. Front Immunol. 13:992370 2022.. doi: 10.3389/fimmu.2022.992370. PubMed Brief Report
Rouco SO, Rodriguez PE, Miglietta EA, Rall P, Ledesma MMGL, Varese A, Pascuale CA, Ojeda DS, Mazzitelli B, Sanchez L, Ceballos A, Perez E, Geffner J, Miragaya Y, Rossi AH, Gamarnik AV. Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people. Lancet Infect Dis. 22(8):1118-1119 2022.. doi: 10.1016/S1473-3099(22)00427-3. PubMed Letter
Castellano LA, McNamara RJ, Pallarés HM, Gamarnik AV, Alvarez DE, Bazzini AA. Dengue virus preferentially uses human and mosquito non-optimal codons. Molecular Systems Biology. 2024 20(10):1085-1108. https://doi.org/10.1038/s44320-024-00052-7 Research article Pubmed
Pallarés HM, González López Ledesma MM, Oviedo-Rouco S, Castellano LA, Costa Navarro GS, Fernández-Alvarez AJ, D'Andreiz MJ, Aldas-Bulos VD, Alvarez DE, Bazzini AA, Gamarnik AV. Zika virus non-coding RNAs antagonize antiviral responses by PKR-mediated translational arrest. Nucleic Acids Research 2024 Jun 25:gkae507. doi: https://doi.org/10.1093/nar/gkae507 Pubmed
Peri Ibáñez ES, Mazzeo A, Silva C, Juncos MJ, Costa Navarro GS, Pallarés HM, Wolos VJ, Fiszman GL, Mundo SL, Caramelo JJ, Yanovsky MJ, Fingermann M, Castello AA, Gamarnik AV, Peinetti AS, Capdevila DA. Overcoming Limited Access to Virus Infection Rapid Testing: Development of a Lateral Flow Test for SARS-CoV-2 with Locally Available Resources. Biosensors. 2024 14(9):416. https://doi.org/10.3390/bios14090416 Research article Pubmed
Bottero D, Rudi E, Martin Aispuro P, Zurita E, Gaillard E, Gonzalez Lopez Ledesma MM, Malito J, Stuible M, Ambrosis N, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D. Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron. Frontiers in Immunology. Nov 10;14:1271209. 2023. doi: 10.3389/fimmu.2023.1271209. PubMed
Giai C, Salassa BN, Zarelli VE, Bello OD, Vanrell MC, Ojeda DS, Gamarnik A, Colombo MI. Comparative analysis of humoral immune response upon the three first vaccines applied in Argentina: IgG production and neutralizing capacity against SARS-CoV-2. Heliyon. 9(5):e15211 2023.. doi: 10.1016/j.heliyon.2023.e15211. PubMed
Gonzalez Lopez Ledesma MM, Costa Navarro G, Pallares HM, Paletta A, De Maio F, Iglesias NG, Gebhard L, Oviedo Rouco S, Ojeda DS, de Borba L, Giraldo M, Rajsbaum R, Ceballos A, Krogan NJ, Shah PS, Gamarnik AV. Dengue virus NS5 degrades ERC1 during infection to antagonize NF-kB activation. Proc Natl Acad Sci U S A. 120(23):e2220005120 2023.. doi: 10.1073/pnas.2220005120. PubMed
Adler NS, Cababie LA, Sarto C, Cavasotto CN, Gebhard LG, Estrin DA, Gamarnik AV, Arrar M, Kaufman SB. Insights into the product release mechanism of dengue virus NS3 helicase. Nucleic Acids Res. 50(12):6968-6979 2022.. doi: 10.1093/nar/gkac473. PubMed
Gabriel MV, Sallaberry I, Costa Navarro GS, Gratton E, Gamarnik AV, Estrada LC. Dengue Virus Capsid-Protein Dynamics in Live Infected Cells Studied by Pair Correlation Analysis. Methods Mol Biol. 2409:99-117 2022.. doi: 10.1007/978-1-0716-1879-0_8. PubMed
Gonzalez Lopez Ledesma MM, Sanchez L, Ojeda DS, Oviedo Rouco S, Rossi AH, Varese A, Mazzitelli I, Pascuale CA, Miglietta EA, Rodríguez PE, Pallarés HM, Costa Navarro GS, Caramelo JJ, Rothlauf PW, Liu Z, Bloyet LM, Cornejo Pontelli M, Rasetto NB, Wenker SD, Ramis LY, Bialer MG, de Leone MJ, Hernando CE, Bianchimano L, Ríos AS, Treffinger Cienfuegos MS, Rodriguez García DR, Longueira Y, Laufer N, Alvarez D, Ceballos A, Ochoa V, Monzani C, Turk G, Salvatori M, Carradori J, Prost K, Rima A, Varela C, Ercole R, Toro RI, Gutierrez S, Zubieta M, Acuña D, Nabaes Jodar MS, Torres C, Mojsiejczuk L, Viegas M, Velazquez P, Testa C, Kreplak N, Yanovsky M, Whelan S, Geffner J, Pifano M, Gamarnik AV. Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time. mBio. 13(1):e0344221 2022.. doi: 10.1128/mbio.03442-21. PubMed
Longueira Y, Ojeda DS, Battistelli RBA, Sanchez L, Oviedo Rouco S, Albano D, Guevara E, Valls V, Pando MA, Gamarnik AV. SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants. Front Immunol. 13:909995 2022.. doi: 10.3389/fimmu.2022.909995. PubMed
Pascuale CA, Varese A, Ojeda DS, Pasinovich ME, Lopez L, Rossi AH, Rodriguez PE, Miglietta EA; Laboratorio SeVa Group, Mazzitelli I, Di Diego Garcia F, Sanchez L, Rouco SO, Gonzalez Lopez Ledesma MM, Zurano JP, Mazzitelli B, Scruzzi G, Barbero P, Cardozo D, Gallego S, Borda M, Diaz M; Ministerio de Salud de la Provincia de Córdoba Group; UNC-Fac. Cs. Médicas-InViV Group, Ridao F, Rosales AB; Ministerio de Salud de la Provincia de La Rioja Group, Bhon J, Talia JM, Diangelo ME, Lacaze MA; Ministerio de Salud de la Provincia de San Luis Group, Aime B, Gutierrez SI, Ercole R, Toro R, Tau L, Delaplace L, Compagnucci MF; Universidad Nacional de La Plata Group, Sartori C, Desimone I, Echegoyen C, Velazquez P, Testa C; Ministerio de Salud de la Provincia de Buenos Aires Group, Hozbor D, Docena G, Laino CH, Kreplak N, Pifano M, Barbas G, Rearte A, Vizzotti C, Castelli JM, Geffner J, Gamarnik AV. Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273. Cell Rep Med. 3(8):100706 2022.. doi: 10.1016/j.xcrm.2022.100706. PubMed
Pecora A, Malacari DA, Mozgovoj MV, Díaz MLA, Peralta AV, Cacciabue M, Puebla AF, Carusso C, Mundo SL, Gonzalez Lopez Ledesma MM, Gamarnik AV, Rinaldi O, Vidal O, Mas J, Dus Santos MJ. Anthropogenic Infection of Domestic Cats With SARS-CoV-2 Alpha Variant B.1.1.7 Lineage in Buenos Aires. Front Vet Sci. 9:790058 2022.. doi: 10.3389/fvets.2022.790058. PubMed
Rodriguez PE, Silva AP, Miglietta EA, Rall P, Pascuale CA, Ballejo C, López Miranda L, Ríos AS, Ramis L, Marro J, Poncet V, Mazzitelli B, Salvatori M, Ceballos A, Gonzalez Lopez Ledesma MM, Ojeda DS, Aguirre MF, Miragaya Y, Gamarnik AV, Rossi AH; Laboratorio SeVa Group; PAMI Group. Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina. Front Immunol. 13:992370 2022.. doi: 10.3389/fimmu.2022.992370. PubMed Brief Report
Rouco SO, Rodriguez PE, Miglietta EA, Rall P, Ledesma MMGL, Varese A, Pascuale CA, Ojeda DS, Mazzitelli B, Sanchez L, Ceballos A, Perez E, Geffner J, Miragaya Y, Rossi AH, Gamarnik AV. Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people. Lancet Infect Dis. 22(8):1118-1119 2022.. doi: 10.1016/S1473-3099(22)00427-3. PubMed Letter